Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 321: Therapeutic uses of alpha-adrenoreceptor blockers include all of the following except?

A. Hypertension
B. Anxiety (Correct Answer)
C. Peripheral vascular disease
D. Benign prostatic hypertrophy

Explanation: **Explanation:** The correct answer is **Anxiety**. Alpha-adrenoreceptor blockers primarily act on the peripheral vasculature and smooth muscles, having no established role in the management of anxiety disorders. Anxiety is typically managed with **Benzodiazepines** (GABA-A modulators) or **SSRIs**. While **Beta-blockers** (like Propranolol) are used to treat the *physical symptoms* of performance anxiety (tachycardia, tremors), alpha-blockers do not cross the blood-brain barrier effectively or target the relevant receptors for anxiolysis. **Analysis of other options:** * **Hypertension:** Selective $\alpha_1$-blockers (e.g., **Prazosin, Terazosin**) cause vasodilation by inhibiting postsynaptic $\alpha_1$ receptors on vascular smooth muscle, thereby reducing peripheral resistance. * **Peripheral Vascular Disease (PVD):** Non-selective alpha-blockers (e.g., **Phenoxybenzamine, Phentolamine**) or $\alpha_1$-blockers can be used to treat Raynaud’s phenomenon or frostbite by relieving vasospasm and improving cutaneous blood flow. * **Benign Prostatic Hypertrophy (BPH):** $\alpha_{1A}$-selective blockers (e.g., **Tamsulosin, Silodosin**) relax the smooth muscles of the bladder neck and prostatic urethra, improving urine flow with minimal effect on systemic blood pressure. **High-Yield Clinical Pearls for NEET-PG:** 1. **Pheochromocytoma:** Phenoxybenzamine (irreversible) is the drug of choice for preoperative management to prevent hypertensive crises. 2. **First-Dose Phenomenon:** Prazosin can cause sudden orthostatic hypotension; it should be started at a low dose at bedtime. 3. **Intraoperative Floppy Iris Syndrome (IFIS):** A known complication of Tamsulosin during cataract surgery. 4. **Cheese Reaction:** Phentolamine is the drug of choice for hypertensive crises associated with MAO inhibitors and tyramine-rich foods.

Question 322: Which of the following drugs is a selective antagonist of M1 muscarinic receptors?

A. Methacholine
B. Bethanechol
C. Methoctramine
D. Pirenzepine (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Pirenzepine** **1. Why Pirenzepine is Correct:** Muscarinic receptors are classified into five subtypes ($M_1$ to $M_5$). **Pirenzepine** (and its analog Telenzepine) is a selective **$M_1$ receptor antagonist**. $M_1$ receptors are primarily located in the gastric glands (oxyntic cells) and autonomic ganglia. By blocking these receptors, Pirenzepine reduces gastric acid secretion. While historically used for peptic ulcer disease, it has largely been replaced by $H_2$ blockers and Proton Pump Inhibitors (PPIs). **2. Analysis of Incorrect Options:** * **A. Methacholine:** This is a non-selective **muscarinic agonist** (cholinomimetic). It is primarily used in the "Methacholine Challenge Test" to diagnose bronchial hyperreactivity in suspected asthma. * **B. Bethanechol:** This is a selective **muscarinic agonist** with significant action on the bladder and GI tract. It is used clinically to treat post-operative urinary retention and paralytic ileus. * **C. Methoctramine:** This is a selective **$M_2$ receptor antagonist**. $M_2$ receptors are predominantly found in the heart; blocking them leads to tachycardia. **3. High-Yield NEET-PG Pearls:** * **M1 Selective Antagonists:** Pirenzepine, Telenzepine (used for Peptic Ulcers). * **M2 Selective Antagonist:** Methoctramine, Gallamine. * **M3 Selective Antagonist:** Darifenacin, Solifenacin (used for Overactive Bladder/Urge Incontinence). * **M3 Selective Agonist:** Cevimeline (used for Sjögren’s syndrome to increase salivation). * **Ipratropium/Tiotropium:** Non-selective muscarinic antagonists used via inhalation for COPD/Asthma to cause bronchodilation.

Question 323: Pralidoxime acts by?

A. Reactivating cholinesterase enzyme (Correct Answer)
B. Promoting synthesis of cholinesterase
C. Promoting synthesis of acetylcholine
D. Direct action on cholinergic receptors

Explanation: **Explanation:** **Pralidoxime (2-PAM)** is a member of the chemical class known as **Oximes**. Its primary mechanism of action is the **reactivation of the enzyme Acetylcholinesterase (AChE)** that has been inactivated by organophosphate (OP) compounds. 1. **Why Option A is Correct:** In organophosphate poisoning, the OP compound binds to the esteratic site of AChE, forming a stable phosphorylated enzyme complex. This prevents the breakdown of Acetylcholine (ACh), leading to a "cholinergic crisis." Pralidoxime has a higher affinity for the phosphate group than the enzyme does. It binds to the OP-enzyme complex, pulls the phosphate group away, and releases the **regenerated (active) enzyme**, allowing it to resume the hydrolysis of ACh. 2. **Why Other Options are Incorrect:** * **Options B & C:** Pralidoxime does not influence the genetic expression or protein synthesis of enzymes or neurotransmitters. It only acts on existing molecules. * **Option D:** Pralidoxime does not bind to nicotinic or muscarinic receptors directly; its effects are mediated solely through the restoration of endogenous enzyme activity. **High-Yield Clinical Pearls for NEET-PG:** * **The "Aging" Phenomenon:** Pralidoxime must be administered early. If the OP-enzyme bond undergoes "aging" (loss of an alkyl group), the bond becomes permanent, and oximes can no longer reactivate the enzyme. * **Site of Action:** Pralidoxime is effective at the **Neuromuscular Junction (NMJ)**, reversing skeletal muscle paralysis. It does **not** cross the Blood-Brain Barrier (BBB) effectively, so it has minimal effect on Central Nervous System (CNS) symptoms. * **Specific Use:** It is used for Organophosphate poisoning but is **contraindicated in Carbamate poisoning** (as the carbamate-enzyme bond is reversible and oximes may worsen the condition). * **Atropine vs. Pralidoxime:** Atropine treats the symptoms (antagonizes receptors), while Pralidoxime treats the cause (reactivates the enzyme).

Question 324: Which of the following is true about tachyphylaxis?

A. It involves direct sympathomimetics.
B. Its mechanism is clearly understood.
C. Tachyphylaxis of ephedrine is reversed with dopamine.
D. It involves indirect sympathomimetics. (Correct Answer)

Explanation: **Explanation:** **Tachyphylaxis** is a phenomenon characterized by a rapid decrease in response to a drug after repeated administration over a short period. **Why Option D is correct:** Tachyphylaxis is most commonly associated with **indirect-acting sympathomimetics** (e.g., Ephedrine, Tyramine, Amphetamine). These drugs work by displacing stored norepinephrine (NE) from the presynaptic nerve terminals into the synaptic cleft. With repeated, frequent dosing, the available stores of NE become depleted faster than they can be replenished. Once the stores are exhausted, further administration of the drug produces no effect, leading to tachyphylaxis. **Analysis of Incorrect Options:** * **Option A:** Direct sympathomimetics (e.g., Epinephrine, Phenylephrine) act directly on receptors. While they can undergo "downregulation" or "desensitization" over long periods, they do not typically cause the rapid tachyphylaxis seen with indirect agents because they do not rely on neurotransmitter stores. * **Option B:** While the depletion of neurotransmitter stores is a primary mechanism, the process can also involve receptor internalization or phosphorylation. However, the statement that it is "clearly understood" is often debated in pharmacology as multiple cellular mechanisms may coexist. * **Option C:** Tachyphylaxis of ephedrine is not reversed by dopamine. It is typically reversed by allowing time for the nerve endings to re-synthesize and restock norepinephrine stores. **NEET-PG High-Yield Pearls:** * **Classic Examples:** Ephedrine (nasal decongestants), Tyramine, Nicotine, and Nitroglycerin (though via a different mechanism involving free radical formation). * **Distinction:** Unlike **tolerance**, which develops slowly (days/weeks), **tachyphylaxis** occurs acutely (minutes/hours). * **Clinical Note:** This is why patients are advised not to use topical nasal decongestants for more than 3–5 days to avoid "rebound congestion" and diminishing efficacy.

Question 325: Which mydriatic agent has no cycloplegic effect?

A. Atropine
B. Phenylephrine (Correct Answer)
C. Tropicamide
D. Homatropine

Explanation: **Explanation:** To understand why **Phenylephrine** is the correct answer, we must distinguish between the two different muscle groups in the eye responsible for pupillary changes: 1. **Dilator Pupillae (Radial muscle):** Controlled by the **Sympathetic** nervous system ($\alpha_1$ receptors). Stimulation causes mydriasis (dilation) without affecting the lens. 2. **Sphincter Pupillae & Ciliary Muscle:** Controlled by the **Parasympathetic** nervous system (M$_3$ receptors). Blocking these causes both mydriasis and **cycloplegia** (paralysis of accommodation). **Why Phenylephrine is correct:** Phenylephrine is a selective **$\alpha_1$-adrenergic agonist**. It acts directly on the dilator pupillae muscle to produce mydriasis. Since it has no effect on the cholinergic receptors of the ciliary muscle, it **does not cause cycloplegia**. This makes it ideal for routine fundus examinations where the patient needs to maintain the ability to focus on near objects. **Why the other options are incorrect:** * **Atropine, Tropicamide, and Homatropine** are all **Antimuscarinic (Anticholinergic) agents**. They block M$_3$ receptors on both the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia). Therefore, they are "cycloplegic mydriatics." **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for Fundoscopy:** Tropicamide (fastest onset, shortest duration among antimuscarinics). * **Drug of choice for Iridocyclitis:** Atropine (prevents synechiae and provides rest to the ciliary muscle, reducing pain). * **Phenylephrine Caution:** It can cause a transient rise in blood pressure and should be used cautiously in hypertensive patients. It is also used to differentiate between scleritis and episcleritis (it blanches episcleral vessels). * **Mnemonic:** **S**ympathetic = **S**pares the ciliary muscle (No cycloplegia).

Question 326: Tubocurarine action is easily reversed by which of the following?

A. Atropine
B. Neostigmine (Correct Answer)
C. Edrophonium
D. Galamin

Explanation: **Explanation:** **Mechanism of Action (The Correct Answer):** Tubocurarine is a **competitive (non-depolarizing) neuromuscular blocking agent** that acts by binding to nicotinic receptors ($N_m$) at the neuromuscular junction, preventing acetylcholine (ACh) from binding. This blockade can be overcome by increasing the concentration of ACh in the synaptic cleft. **Neostigmine** is an acetylcholinesterase inhibitor; it prevents the breakdown of ACh, thereby increasing its levels. The excess ACh competes with and displaces Tubocurarine from the receptors, effectively reversing the muscle paralysis. **Analysis of Incorrect Options:** * **Atropine (A):** This is a muscarinic antagonist. While it is often co-administered with Neostigmine to prevent bradycardia and excessive secretions (muscarinic side effects), it has no effect on the $N_m$ receptors and cannot reverse muscle paralysis. * **Edrophonium (C):** Although it is an anticholinesterase, it is very short-acting. It is primarily used for the diagnosis of Myasthenia Gravis (Tensilon test) rather than the clinical reversal of long-acting neuromuscular blockers like Tubocurarine. * **Gallamine (D):** This is another non-depolarizing neuromuscular blocker. It would potentiate the action of Tubocurarine rather than reverse it. **NEET-PG High-Yield Pearls:** * **Reversal Cocktail:** In clinical practice, Neostigmine is always given with an antimuscarinic (Atropine or Glycopyrrolate) to block unwanted parasympathetic effects. * **Sugammadex:** A newer agent used specifically for the rapid reversal of Aminosteroid NMBs (Rocuronium > Vecuronium) by chelation, not by enzyme inhibition. * **Hoffman Elimination:** Remember that Atracurium and Cisatracurium do not require hepatic/renal metabolism but undergo spontaneous degradation.

Question 327: Which direct-acting cholinomimetic, being lipid-soluble, has been used in the treatment of glaucoma?

A. Acetylcholine
B. Physostigmine
C. Pilocarpine (Correct Answer)
D. Neostigmine

Explanation: ### Explanation **Correct Option: C. Pilocarpine** Pilocarpine is a **direct-acting cholinomimetic** alkaloid that acts primarily on Muscarinic ($M_3$) receptors [2]. It is a tertiary amine, making it **lipid-soluble** and capable of penetrating the cornea effectively [2]. In glaucoma, it causes contraction of the ciliary muscle (increasing aqueous outflow through the trabecular meshwork) and the sphincter pupillae (causing miosis) [1]. This makes it a classic drug for treating both open-angle and acute angle-closure glaucoma [1]. **Analysis of Incorrect Options:** * **A. Acetylcholine:** While it is a direct-acting agonist, it is a quaternary ammonium compound (polar/water-soluble) with an extremely short half-life due to rapid degradation by pseudocholinesterase. It is not used clinically for glaucoma. * **B. Physostigmine:** Although it is lipid-soluble and used in glaucoma, it is an **indirect-acting** cholinomimetic (acetylcholinesterase inhibitor), not a direct-acting one. * **D. Neostigmine:** This is an indirect-acting cholinomimetic and a quaternary ammonium compound. Being **water-soluble (polar)**, it does not penetrate the cornea or the blood-brain barrier effectively. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Pilocarpine is the DOC for the emergency management of **Acute Angle-Closure Glaucoma** (to break the pupillary block) [1]. * **Side Effects:** A common side effect is "brow ache" due to ciliary muscle spasm and fixed small pupils (difficulty seeing in the dark). * **Adie’s Tonic Pupil:** Diagnosis is confirmed using **dilute pilocarpine (0.125%)**, which causes constriction in the affected eye due to cholinergic supersensitivity. * **Sjögren’s Syndrome:** Oral pilocarpine is used to treat xerostomia (dry mouth) [2].

Question 328: What is the mechanism of action of curare?

A. Reducing end-plate potential (Correct Answer)
B. Reducing presynaptic potential
C. Inhibiting channels
D. Inhibiting Na+ channels

Explanation: ### Explanation **Mechanism of Action: Curare (d-Tubocurarine)** Curare is a prototype **non-depolarizing neuromuscular blocking agent**. It acts as a competitive antagonist at the nicotinic acetylcholine receptors ($N_M$) located on the motor end-plate of the neuromuscular junction. 1. **Why Option A is Correct:** By competitively binding to $N_M$ receptors, curare prevents Acetylcholine (ACh) from binding. This prevents the opening of cation channels, leading to a **reduction in the magnitude of the End-Plate Potential (EPP)**. When the EPP fails to reach the threshold required to trigger an action potential in the muscle fiber, muscle contraction is inhibited, resulting in flaccid paralysis. 2. **Why Other Options are Incorrect:** * **B. Reducing presynaptic potential:** Curare acts post-synaptically at the motor end-plate. Drugs affecting presynaptic potentials or release include Botulinum toxin or Hemicholinium. * **C & D. Inhibiting channels:** While curare prevents channel opening indirectly by blocking the receptor site, it is not classified as a direct channel blocker (like certain toxins or local anesthetics). Specifically, **Option D** refers to the mechanism of Local Anesthetics or Tetrodotoxin, which block voltage-gated $Na^+$ channels, not the ligand-gated channels at the end-plate. ### NEET-PG High-Yield Pearls * **Reversibility:** The blockade produced by curare can be reversed by increasing the concentration of ACh using **Acetylcholinesterase inhibitors** (e.g., Neostigmine). * **Order of Paralysis:** Small, rapidly moving muscles (eyes, fingers) are paralyzed first; the **diaphragm** is the last to be paralyzed and the first to recover. * **Adverse Effects:** d-Tubocurarine is known for causing **histamine release**, leading to bronchospasm and hypotension. * **Antidote:** Neostigmine (usually co-administered with Glycopyrrolate to prevent muscarinic side effects) or Sugammadex (specifically for Rocuronium/Vecuronium).

Question 329: Anti-muscarinic drugs are used for all of the following indications EXCEPT?

A. Hypertension (Correct Answer)
B. Motion sickness
C. Parkinson's disease
D. To produce mydriasis and cycloplegia

Explanation: **Explanation:** **1. Why Hypertension is the Correct Answer:** Anti-muscarinic drugs (like Atropine) block M2 receptors in the heart and M3 receptors in the vasculature. Blocking M2 receptors leads to **tachycardia** (increased heart rate), which can actually increase cardiac output and blood pressure. Furthermore, anti-muscarinics have no role in lowering peripheral resistance. Therefore, they are **contraindicated** or ineffective in hypertension. In fact, they are used to treat *bradycardia* and *hypotension* (e.g., Atropine in ACLS). **2. Why the Other Options are Incorrect (Indications for Use):** * **Motion Sickness:** Centrally acting anti-muscarinics like **Scopolamine (Hyoscine)** block M1 receptors in the vestibular apparatus and vomiting center, making them the drug of choice for prophylaxis. * **Parkinson’s Disease:** Centrally acting agents like **Trihexyphenidyl (Benzhexol)** and **Benztropine** are used to correct the cholinergic-dopaminergic imbalance, specifically helping with tremors and rigidity. * **Mydriasis and Cycloplegia:** Drugs like **Atropine, Homatropine, and Cyclopentolate** block M3 receptors on the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia/paralysis of accommodation). This is essential for accurate refractive testing and fundus examination. **Clinical Pearls for NEET-PG:** * **Drug of choice for Mushroom poisoning (Mycetism):** Atropine. * **Ipratropium/Tiotropium:** M3 blockers used as bronchodilators in COPD and Asthma. * **Oxybutynin/Darifenacin:** M3 selective blockers used for Overactive Bladder (Urge incontinence). * **Contraindication:** Anti-muscarinics must be avoided in patients with **Angle-closure Glaucoma** and **Benign Prostatic Hyperplasia (BPH)**.

Question 330: Tyramine acts by:

A. Inhibiting acetylcholinesterase
B. Stimulating co-receptors
C. Releasing norepinephrine (Correct Answer)
D. Stimulating beta-3 receptors

Explanation: **Explanation:** **Tyramine** is a classic example of an **indirectly acting sympathomimetic**. It does not act directly on adrenergic receptors. Instead, it is taken up into the presynaptic nerve terminal via the Norepinephrine Transporter (NET). Once inside, it enters the storage vesicles through the Vesicular Monoamine Transporter (VMAT), displacing **Norepinephrine (NE)** into the cytoplasm. This high concentration of cytoplasmic NE causes the NET to work in reverse, pumping NE into the synaptic cleft, where it activates post-synaptic receptors. **Analysis of Options:** * **A. Inhibiting acetylcholinesterase:** This is the mechanism of action for parasympathomimetics like Neostigmine or Organophosphates, which increase acetylcholine levels. * **B. Stimulating co-receptors:** Tyramine specifically targets the displacement of primary neurotransmitters (NE) rather than modulating co-receptors (like NPY or ATP). * **D. Stimulating beta-3 receptors:** Direct stimulation of $\beta_3$ receptors is seen with drugs like Mirabegron (used for overactive bladder). **High-Yield Clinical Pearls for NEET-PG:** * **The Cheese Reaction:** Tyramine is found in fermented foods (aged cheese, red wine, pickled fish). It is normally metabolized by **MAO-A** in the gut. In patients taking **MAO inhibitors**, tyramine reaches the systemic circulation in high amounts, leading to a massive release of NE and a life-threatening **Hypertensive Crisis**. * **Tachyphylaxis:** Tyramine shows the phenomenon of tachyphylaxis (rapidly diminishing response to repeated doses) because it depletes the available stores of NE. * **Drug Interaction:** The effects of Tyramine are blocked by **Reserpine** (which inhibits VMAT) and **Cocaine/TCAs** (which inhibit NET).

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free